BMN 190
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BMN 190, covering 2018-06-11 to 2022-08-24. Get the full timeline:
Most recent: Clinical Trial Update: An Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 190 in Patients With CLN2 Disease [Phase 1, Phase 2]